A new test for the early detection of Alzheimer’s Disease — potentially even before symptoms are present — show that the diagnostic caught the neurodegenerative disease in 100% of the… Read More
Alzheimer’s disease researchers were buoyed by positive data released Tuesday from a large clinical trial of an experimental therapy being developed by Biogen and Eisai. The early data suggest that… Read More
A $40.5 million collaborative research center headquartered at Seattle’s Allen Institute aims to create high-resolution maps of brains ravaged by Alzheimer’s disease, to trace new paths to early diagnosis and… Read More
Seattle-based nonprofit Sage Bionetworks is leading a heavily funded national effort to find new drugs to fight Alzheimer’s, a disease that has stymied the efforts of big pharma for decades.… Read More